- Home
- PFO vs RPTX Comparison
PFO vs RPTX Comparison
Compare PFO & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFO
- RPTX
- Stock Information
- Founded
- PFO 1991
- RPTX 2016
- Country
- PFO United States
- RPTX Canada
- Employees
- PFO N/A
- RPTX N/A
- Industry
- PFO Finance Companies
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- PFO Finance
- RPTX Health Care
- Exchange
- PFO Nasdaq
- RPTX Nasdaq
- Market Cap
- PFO 123.7M
- RPTX 141.1M
- IPO Year
- PFO N/A
- RPTX 2020
- Fundamental
- Price
- PFO $9.08
- RPTX $1.32
- Analyst Decision
- PFO
- RPTX Strong Buy
- Analyst Count
- PFO 0
- RPTX 3
- Target Price
- PFO N/A
- RPTX $7.00
- AVG Volume (30 Days)
- PFO 31.8K
- RPTX 709.5K
- Earning Date
- PFO 01-01-0001
- RPTX 11-07-2024
- Dividend Yield
- PFO 6.51%
- RPTX N/A
- EPS Growth
- PFO N/A
- RPTX N/A
- EPS
- PFO N/A
- RPTX N/A
- Revenue
- PFO N/A
- RPTX $66,524,000.00
- Revenue This Year
- PFO N/A
- RPTX $13.22
- Revenue Next Year
- PFO N/A
- RPTX N/A
- P/E Ratio
- PFO N/A
- RPTX N/A
- Revenue Growth
- PFO N/A
- RPTX 18.19
- 52 Week Low
- PFO $6.90
- RPTX $1.23
- 52 Week High
- PFO $8.51
- RPTX $8.49
- Technical
- Relative Strength Index (RSI)
- PFO 40.11
- RPTX 30.27
- Support Level
- PFO $9.01
- RPTX $1.23
- Resistance Level
- PFO $9.28
- RPTX $4.07
- Average True Range (ATR)
- PFO 0.09
- RPTX 0.34
- MACD
- PFO -0.01
- RPTX -0.20
- Stochastic Oscillator
- PFO 25.81
- RPTX 3.34
About PFO Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated
Flaherty & Crumrine Prfd Income Oppo is the United States-based diversified, closed-end investment company. Its primary investment objective is to produce high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada.